肝细胞癌经动脉栓塞治疗当前趋势:技术横断面调查
该匿名在线调查通过邮件向五大介入放射学会会员发放18个问题,共获62个国家1160份回复,按地区分析。结果显示,各地区在TACE技术方面几乎全部问题存在统计学显著差异:北美、欧洲和韩国更常用多柔比星,北美和欧洲单发及多发肝细胞癌更常用药物洗脱微球TACE,日本、韩国和中国更常用传统TACE;所有受访者随访最常用CT,北美和学术中心更常用MR。
要点
- 北美、欧洲、韩国受访者较多柔比星的使用比日本和中国更常见(p=0.0001)。
- 单发及多发肝细胞癌中,药物洗脱微球TACE在北美和欧洲最常用,传统TACE在日本、韩国和中国最常用(p=0.0001)。
- 所有受访者随访最常用CT,但北美和学术中心更常用MR(p=0.0001)。
核心结论
- 该调查提供了肝细胞癌经动脉化疗栓塞(TACE)当前实践模式的全面信息,并证实其技术选择存在异质性。
研究设计与样本
- 匿名18题在线调查,通过邮件发放给五大介入放射学会执业会员,中英文版本,共获62个国家1160份回复。
- 回复按执业地区分类,使用Fisher精确检验和卡方检验(必要时Bonferroni校正)分析。
诊断标准与关键数值
- 单发及多发肝细胞癌:北美和欧洲药物洗脱微球TACE最常用(p=0.0001),日本、韩国和中国传统TACE最常用(p=0.0001)。
- 多柔比星在北美、欧洲和韩国受访者中比日本和中国更常用(p=0.0001)。
- 随访影像:所有受访者最常用CT,北美和学术中心更常用MR(p=0.0001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Despite being accepted as a mainstay of treatment for hepatocellular carcinoma (HCC), technical aspects of transarterial chemoembolization (TACE) continue to vary by reporting author, leading to heterogeneity in the literature and making meaningful comparisons between treatments difficult. The goal of this survey was to report international chemoembolization practices for the treatment of HCC in an effort to understand current treatment strategies as a first step towards technique standardization.
MATERIALS AND METHODS: An anonymous 18-question online survey, evaluating technical aspects of their TACE practice, was distributed via email to practicing members of the five largest interventional radiology societies in Chinese and English. A total of 1160 responses were obtained from 62 countries. Responses were categorized according to region of practice and analyzed using Fisher's exact test and chi-square test with Bonferroni correction as needed.
RESULTS: There were significant statistical differences between regions for nearly all questions. Doxorubicin was more commonly used among respondents from North America, Europe, and South Korea than Japan and China (p = 0.0001). For single and multiple HCCs, drug-eluting bead TACE was most popular in North America and Europe (p = 0.0001), while conventional TACE was most popular in Japan, Korea, and China (p = 0.0001). CT was the most commonly used modality for follow-up among all respondents, although MR was used more commonly in North America and in academic centers (p = 0.0001).
CONCLUSION: This survey provides comprehensive information on and confirms the heterogeneous nature of current practice patterns in regard to TA(C)E for HCC.
KEY POINTS: • There is a lack of information regarding current practice patterns in the area of technical considerations when performing transarterial chemoembolization. • Type of transarterial chemoembolization utilized to treat hepatocellular carcinoma varies widely across geographical area. • Chemotherapeutic agents and embolic agents used to perform transarterial chemoembolization for the treatment of hepatocellular carcinoma vary widely across geographical areas.
引用
- Young S, Craig P, Golzarian J, et al. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques. Eur Radiol. 2018. PMID: 30350163. doi:10.1007/s00330-018-5782-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。